Search results
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
CNBC· 7 hours agoLeading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France...
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 4 days agoPfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn...
Pfizer Agrees to Settle More Than 10,000 Zantac Cancer Lawsuits
Insurance Journal· 4 days agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...
Amazon, Morgan Stanley, Pfizer to Announce French Investments
Bloomberg via Yahoo Finance· 7 hours ago(Bloomberg) -- Amazon.com Inc., Pfizer Inc. and Morgan Stanley are among the companies poised to...
Pfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen Next
Simply Wall St. via Yahoo Finance· 1 day agoPfizer Inc. (NYSE:PFE) just released its first-quarter report and things are looking bullish. It was...
Pfizer announces 500 million euros investment in France
Reuters via Yahoo Finance· 12 hours agoPARIS, May 12 (Reuters) - U.S. pharmaceutical and healthcare giant Pfizer announced on Sunday a 500 million-euro ($538 million) investment in France for research and development ...
France secures jobs, investments from Amazon, Pfizer and Morgan Stanley
Reuters· 6 hours agoMacron wants to burnish Paris' role as a top European business capital as the French economy faces a...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoStrengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent...
Pfizer Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 4 days agoPfizer Inc (NYSE:PFE) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-09. As investors...
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 6 days agoSTOCK ALERT Andrew Baum, the prominent Wall Street drug company analyst, has never been much of a...
